Last reviewed · How we verify
NCT05510661: EPISOO
Use of Export in Primary Percutaneous Coronary Intervention
NA trial testing Export Catheter in ST-segment Elevation Myocardial Infarction (STEMI) in 300 participants. Participants enrolled and being followed up; not accepting new ones.
24 September 2025
Quick facts
| Lead sponsor | National Institute of Cardiovascular Diseases, Pakistan |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 15 January 2024 |
| Primary completion | 24 September 2025 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Export Catheter
- Balloon catheter
Conditions studied
- ST-segment Elevation Myocardial Infarction (STEMI) — all drugs for ST-segment Elevation Myocardial Infarction (STEMI) →
- Total Occlusion of Coronary Artery — all drugs for Total Occlusion of Coronary Artery →
- Primary Percutaneous Coronary Intervention — all drugs for Primary Percutaneous Coronary Intervention →
Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Who can join
18 and older, any sex, with ST-segment Elevation Myocardial Infarction (STEMI) or Total Occlusion of Coronary Artery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05510661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ST-segment Elevation Myocardial Infarction (STEMI)
Currently open trials in the same condition.
- NCT06951724 — Coronary Aspiration Catheter Clinical Trial · NA · recruiting
- NCT06769256 — Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden · Phase 4 · recruiting
- NCT06385834 — The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients Af · NA · recruiting
- NCT06586424 — The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Eleva · recruiting
- NCT05709626 — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction · Phase 4 · recruiting
Other National Institute of Cardiovascular Diseases, Pakistan trials
Trials by the same sponsor.
- NCT07229248 — DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial · Phase 3 · recruiting
- NCT07355452 — Comparing Outcomes Of Single Layer Versus Multilayer Leg Closure Techniques Following Great Saphenous Vein Harvesting Fo · NA · enrolling by invitation
- NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
- NCT06742567 — Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction · Phase 3 · recruiting
- NCT06318481 — TADCLOT- a Double Blind Randomized Controlled Trial · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05510661 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Cardiovascular Diseases, Pakistan
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05510661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing